A recombinant bacterium with improved production intensity of long-chain dibasic acid and its application
By overexpressing the Inh1 gene in yeast, inhibiting the activity of ATP synthase and enhancing the glycolytic pathway, the problem of low production intensity of long carbon chain dibasic acid in microbial fermentation method is solved, and the effect of significantly improving yield and yield is achieved.
Patent Information
- Application Number
- CN202410400413.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-03
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2044-04-03
AI Technical Summary
The prior art is difficult to effectively improve the production intensity of long-carbon chain dibasic acids, especially in microbial fermentation methods. How to improve the efficiency of glucose utilization by yeast cells and reduce the β-oxidation catabolic energy of long-carbon chain dibasic acids , thereby increasing yield and yield is an urgent problem.
By overexpressing the Inh1 gene in yeast, the activity of ATP synthase is inhibited, the level of mitochondrial oxidative phosphorylation is reduced, the glycolysis pathway is enhanced, the efficiency of the strain's utilization of glucose is improved, and the recombinant strain is constructed through recombinant plasmids to enhance its glycolysis level and growth rate to reduce the decomposition and utilization of the generated carbon chain dibasic acid.
The fermentation yield and fermentation intensity of long-carbon chain dibasic acids have been significantly improved, the growth rate of strains and the consumption rate of glucose have been enhanced, and the production of dodecano, thirteen and hexadecano long-carbon dibasic acids have been improved.
Smart Images

Figure CN118147198B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of fermentation engineering, and in particular relates to a recombinant bacterium with improved production intensity of long-chain dibasic acids and an application thereof. Background Art
[0002] Long-chain dicarboxylic acid refers to dicarboxylic acids with 8-20 carbon atoms in the carbon chain, including saturated and unsaturated dicarboxylic acids. It is a widely used industrial raw material that can be used in the fields of high-end engineering plastics, fragrances, coating synthesis, and biopharmaceutical production. Long-chain dicarboxylic acids have two carboxyl groups and have typical properties of carboxylic acids. They can be condensed with hydroxyl groups to form esters under the action of enzymes or other chemical substances. It has a wide range of industrial applications and can be used as a raw material for polyesters and polyamides. It plays an important role in the synthesis and manufacture of high-end engineering plastics, long-chain nylon products, and synthetic fibers. It can also be used as a lubricant, wax, and an ingredient in cosmetics. It also has important uses in the preparation of dyes, resins, and rubbers. Since long-chain dicarboxylic acids are synthetic raw materials for a variety of substances, the current social demand for long-chain dicarboxylic acids is increasing. How to improve its production efficiency and reduce its production cost is an urgent problem to be solved in the industry.
[0003] There are three main methods for producing long-chain dibasic acids: catalytic oil method, chemical synthesis method and microbial fermentation method. The catalytic oil method mainly uses plant oils to produce acid, but there are few acid types, and plant oils are limited by climate and other conditions, so they are not universal; the chemical synthesis method has a complex process and causes great environmental pollution. At present, the production of long-chain dibasic acids is gradually shifting from chemical synthesis to preparation through microbial fermentation. Microbial fermentation has more advantages than chemical synthesis, such as high conversion rate of raw materials, low pollution and low cost.
[0004] At present, the production of long-chain dibasic acids by microbial fermentation has become a hot topic of research at home and abroad as an alternative green and environmentally friendly method. To obtain high-yield long-chain dibasic acids through microbial fermentation, the strain and its metabolic pathway are the key. Because the production of long-chain dibasic acids is closely related to the regulation of metabolic pathways, the production process needs to increase the utilization of glucose by yeast cells as much as possible to obtain energy, reduce the β-oxidation catabolism of long-chain dibasic acids by yeast cells, and thus increase the production and yield of long-chain dibasic acids in yeast.
[0005] Therefore, obtaining higher long-chain dibasic acid yields / rates by intervening and modifying metabolic pathways is a potentially effective strategy, and choosing which metabolic pathway to regulate and intervene is a scientific and technical issue that technicians in this field urgently need to solve. Summary of the invention
[0006] The main purpose of the present invention is to increase the yield of long carbon chain dibasic acids. The purpose of the present invention is not limited to the described subject matter, and those skilled in the art can clearly understand other purposes not mentioned herein through the following description.
[0007] The present invention firstly protects a recombinant plasmid, wherein the recombinant plasmid carries the Inh1 gene shown in SEQ ID NO.1 (NCBI Gene ID: 851347, 258 bp in total), and the expression vector is pGAPZαA.
[0008] The method for constructing the above recombinant plasmid comprises the following steps:
[0009] The Inh1 gene was inserted between the EcoR I and Xba I sites of the pGAPZαA expression vector to obtain the recombinant plasmid.
[0010] The present invention also protects the application of the recombinant plasmid, which is A1) or A2):
[0011] A1) improving the long-chain dicarboxylic acid production intensity of the long-chain dicarboxylic acid producing strain;
[0012] A2) Constructing recombinant bacteria with improved production intensity of long-chain dibasic acids.
[0013] In a specific embodiment of the present invention, the long-chain dibasic acid-producing strain is a Candida tropicalis mutant strain PF-UV-56 with a deposit number of CGMCCNO.0356.
[0014] The present invention has found through a large number of experiments that Inh1 is an inhibitory molecule of ATP synthase. After binding to ATP synthase, it can inhibit the activity of ATP synthase, thereby reducing the level of mitochondrial oxidative phosphorylation. By constitutively overexpressing Inh1 in yeast, the activity of ATP synthase can be further inhibited. In this case, the cell turns to glycolysis for energy gain, and the glycolysis level increases significantly to obtain energy currency ATP to maintain the body's energy consumption. Therefore, overexpressing Inh1 in yeast can enhance the glycolysis level of Candida albicans producing long carbon chain dibasic acids through metabolic reprogramming. The improvement of glycolysis is closely related to cell proliferation, etc. The glycolysis pathway can provide many intermediate metabolites, such as ribulose 5-phosphate, glyceraldehyde triphosphate, etc. to quickly support cell proliferation, thereby increasing the fermentation intensity of the strain. Therefore, by overexpressing Inh1 in long-chain dicarboxylic acid-producing yeast, the growth rate of the strain can be increased, and the intake and utilization of carbon sources such as glucose can be enhanced. At the same time, due to the reduction in the intensity of oxidative phosphorylation metabolism and the downregulation of the TCA cycle, the β-oxidation decomposition (production of acetyl-CoA) of the long-chain dicarboxylic acids produced in the cell will be reduced, thereby increasing the production and yield of long-chain dicarboxylic acids.
[0015] The present invention also protects a recombinant bacterium with improved production intensity of long-chain dibasic acid, wherein the recombinant bacterium carries the recombinant plasmid, and the recipient bacterium is a Candida tropicalis mutant strain PF-UV-56, and the preservation number of the Candida tropicalis mutant strain PF-UV-56 is CGMCC NO.0356.
[0016] The method for constructing the above-mentioned recombinant bacteria comprises the following steps:
[0017] The recombinant plasmid was linearized with endonuclease Avr II and then transferred into the tropical Candida mutant strain PF-UV-56. The recombinant bacteria were obtained by screening positive clones.
[0018] The present invention also protects the use of the recombinant bacteria in the fermentation production of long-chain dibasic acids.
[0019] The molecular formula of the long carbon chain dibasic acid of the present invention is: HOOC-(CH2) n -COOH, n is 8 to 20.
[0020] Herein, the long carbon chain dibasic acid includes a dodecacarbon long carbon chain dibasic acid, a thirteencacarbon long carbon chain dibasic acid and a hexadecane long carbon chain dibasic acid.
[0021] The present invention also protects a method for producing long-chain dibasic acids, which uses the recombinant bacteria, takes dodecane, tridecane and / or hexadecane as substrates, carries out fermentation culture, collects the fermentation products, and obtains dodecane long-chain dibasic acids, tridecane long-chain dibasic acids and / or hexadecane long-chain dibasic acids.
[0022] In a specific embodiment of the present invention, the method comprises: picking a single colony of the recombinant bacteria and activating and culturing it on a seed culture medium for 24 hours, inoculating the activated cultured seed solution into a fermentation medium at an inoculation rate of 20%, and fermenting and culturing at 30°C and 300rpm. After 48 hours, according to the fermentation volume, 2% of fresh fermentation medium is added every day, and at the same time, 2% (V / V) of dodecane, tridecane or hexadecane is added every day, respectively, for 4 consecutive days, and a total of 144 hours (6 days) of culturing is performed.
[0023] Compared with the prior art, the present invention has the following beneficial effects:
[0024] The present invention firstly finds that by constitutively overexpressing a key metabolic gene Inh1 (NCBI Gene ID: 851347, 258 bp in total) in a long-chain dicarboxylic acid producing strain (CGMCC NO.0356), the glycolysis level thereof is enhanced, the utilization efficiency of glucose by the strain is enhanced, the growth rate thereof is increased, and the decomposition and utilization of the generated long-chain dicarboxylic acid is reduced, thereby increasing the fermentation yield and fermentation intensity of the long-chain dicarboxylic acid (dodecane long-chain dicarboxylic acid, thirteen carbon long-chain dicarboxylic acid and / or hexadecane long-chain dicarboxylic acid). BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 Schematic diagram of the pGAPZαA / Inh1 recombinant plasmid structure. DETAILED DESCRIPTION
[0026] The present invention will be described in detail below with reference to the accompanying drawings and specific embodiments, but they should not be construed as limitations of the present invention.
[0027] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention.
[0028] Unless otherwise specified or there is a contradiction, the terms or phrases used in this invention have the following meanings:
[0029] The optional scope of the terms "and / or", "or / and", and "and / or" used in this article includes any one of two or more related listed items, and also includes any and all combinations of the related listed items, said any and all combinations include any combination of any two related listed items, any more related listed items, or all related listed items.
[0030] In the present invention, "one or several" refers to any one, any two or any two or more of the listed items. Among them, "several" refers to any two or any two or more.
[0031] The “combinations thereof”, “any combinations thereof”, “any combination thereof” etc. used in the present invention include all suitable combinations of any two or more of the listed items.
[0032] In the present invention, the “suitable” mentioned in “suitable combination”, “suitable method”, “any suitable method”, etc. shall be based on the ability to implement the technical solution of the present invention, solve the technical problem of the present invention, and achieve the expected technical effect of the present invention.
[0033] In the present invention, “preferred” is only used to describe an implementation method or example with better effects, and it should be understood that it does not constitute a limitation on the protection scope of the present invention.
[0034] In the present invention, the technical features described in an open manner include closed technical solutions composed of the listed features, and also include open technical solutions containing the listed features.
[0035] In the present invention, when a numerical range is involved, unless otherwise specified, the two endpoints of the numerical range are included.
[0036] The percentage content involved in the present invention, unless otherwise specified, refers to mass percentage for solid-liquid mixing and solid-solid mixing, and refers to volume percentage for liquid-liquid mixing.
[0037] The percentage concentrations involved in the present invention, unless otherwise specified, refer to the final concentration. The final concentration refers to the proportion of the added component in the system after the addition of the component.
[0038] The temperature parameters in the present invention, if not specifically limited, allow for both constant temperature treatment and treatment within a certain temperature range. The constant temperature treatment allows the temperature to fluctuate within the precision range controlled by the instrument.
[0039] The experimental methods without specific conditions and the reagents without formulas in the present invention are based on conventional conditions, such as the conditions described in Medical Biochemistry and Molecular Biology Experimental Course, 2011 edition, Higher Education Press.
[0040] Strains and plasmids: The long-chain dicarboxylic acid producing strain (CGMCC NO.0356) has been deposited and provided by Qingdao Duoyuan Bioengineering Technology Co., Ltd., and is disclosed in the Chinese invention patent No. ZL200310104982.0. The yeast expression plasmid pGAPZαA is a shuttle vector between E. coli and yeast, and the selection markers in E. coli and yeast are both Zeocin.
[0041] Determination of bacterial growth: 100 μL of sample was collected under aseptic conditions in a clean bench every day, added to 900 μL of sterile water, mixed thoroughly, and the OD value was measured at 570 nm using a UV7500 visible light spectrophotometer to draw a growth curve.
[0042] Determination of dry weight of bacteria: Take a certain amount of bacterial suspension in a 10mL volumetric flask, add 2mL of hydrochloric acid (2mol / L) to dissolve the calcium carbonate in the suspension, add deionized water to make up to 10mL, mix thoroughly, use UV7500 visible light spectrophotometer to measure the OD value at 660nm, and calculate the cell dry weight using the cell dry weight standard curve.
[0043] Determination of long-chain dibasic acids: Accurately pipette 5-8mL of fermentation broth, add 0.5mL of 4mol / L NaOH solution, boil in water for 5min, mix well, cool with tap water, place in a centrifuge tube, centrifuge at 4000rpm for 10min, pipette 4mL of the middle aqueous phase into a 50mL conical flask, drop 3mol / L sulfuric acid solution until the pH is acidic (generally between 2-3), so that the dibasic acid is completely crystallized. Filter, and wash the conical flask and filter cake with deionized water until the filtrate and filter paper are neutral. Transfer the filter cake and filter paper into a 150mL conical flask, add 25-30mL 95% ethanol as solvent, heat to completely dissolve the dibasic acid, add 2-3 drops of bromothymol blue as an indicator, and titrate to the end point with NaOH standard solution.
[0044] The concentration calculation formula of long carbon chain dibasic acid (DCA) is:
[0045] C DCA12 or DCA13 or DCA16 =0.5×244×C NaOH ×V NaOH / (4×V / (V+0.5))
[0046] Among them, C DCA12 is the concentration of DCA12 (g / L); C DCA13 is the concentration of DCA13 (g / L); C DCA16 is the concentration of DCA16 (g / L);
[0047] C NaOH ——Equivalent concentration for titration (mol / L);
[0048] V NaOH ——Volume of NaOH used for titration (mL);
[0049] V——sampling volume (mL).
[0050] Note: The determination methods of dibasic acid production mentioned in this method are all to measure the dibasic acid content of the whole fermentation broth. DCA is the abbreviation of long carbon chain dibasic acid.
[0051] Determination of glucose: Sample preparation: 1 mL of fermentation broth was centrifuged at 12,000 rpm for 5 min, and the supernatant was appropriately diluted and filtered through a 0.22 μm filter membrane before being analyzed by high performance liquid chromatography. Instrument: Agilent 1260 high performance liquid chromatograph, chromatographic conditions: chromatographic column: Aminex HPX-87H ion exchange column, mobile phase: 5 mM H2SO4, flow rate: 0.6 mL / min, column temperature: 40 °C, injection volume: 10 μL, and determination was performed using a differential refractometer.
[0052] Culture medium:
[0053] LB liquid or solid medium: 10 g yeast extract, 5 g peptone, 10 g NaCl, dilute to 1 L. Add 2% agar powder to make it a fixed medium, sterilize at 115°C for 15 min. Add Zeocin (100 μg / ml) to the screening medium.
[0054] YPD solid medium: 10 g yeast extract, 20 g peptone, 20 g glucose, dilute to 1 L. Add 2% agar powder to make it a fixed medium, sterilize at 115°C for 15 min. Add Zeocin (100 μg / ml) to the screening medium.
[0055] Seed culture medium (g / L): yeast extract 0.5%, corn syrup 0.3%, sucrose 2%, urea 0.3%, KH2PO4 0.8%, sterilized at 115℃ for 15min.
[0056] Fermentation medium (g / L): glucose 120g, yeast extract 2g, corn syrup 2g, urea 3.86g, MgSO4.7H200.8g, KH2PO4 2g, CH3OONa 3g, trace element solution (filter sterilized) 10mL, vitamin solution (filter sterilized) 10mL, sterilized at 115℃ for 15min. 40g / L NaOH (sterilized separately) was added to adjust pH. The formula of trace element solution is: MnCl2·4H2O, 12g; FeSO4·7H2O, 2g; CaCl2·2H2O, 2g; CuSO4·5H2O, 0.05g; ZnCl2, 0.5g, dissolved with 2mol / L HCl and fixed to 1L. Vitamin solution formula: biotin 0.004 g, thiamine 0.75 mg, pyridoxine 0.04 g, niacin 0.8 g, dissolved in 2 mol / L HCl and fixed to 1 L; dodecanes, tridecanes and hexadecanes: sterilized at 115°C for 15 min respectively.
[0057] Example 1: Amplification of yeast Inh1 and construction of expression plasmid
[0058] A target gene Inh1 fragment (shown in SEQ ID NO.1 and an amino acid sequence shown in SEQ ID NO.2) with EcoR I / Xba I restriction site fragments at both ends was obtained by a gene total synthesis method, and the target gene fragment was obtained after separation and purification by agarose gel electrophoresis. The target gene Inh1 was double-digested with restriction endonucleases EcoR I and Xba I, concentrated and purified, and the Inh1 gene was directionally cloned into an expression plasmid pGAPZαA to obtain a recombinant yeast expression plasmid pGAPZαA / Inh1. The above recombinant expression plasmid was transformed into competent cells DH5α and coated on an agar powder LB plate containing Zeocin (100 μg / ml) for screening.
[0059] Positive clones were selected and cultured overnight in LB liquid medium containing Zeocin (100 μg / ml). The plasmid was extracted the next day (according to the instructions of the plasmid extraction kit of Tiangen Biochemical Technology (Beijing) Co., Ltd., catalog number #DP103). After EcoR I / Xba I double enzyme digestion, it was sent to the company for sequencing and confirmed to be correct.
[0060] SEQ ID NO.1:ATGTTACCACGTTCAGCATTAGCACGCTCATTGCAATT ACAGCGCGGTGTGGCCGCAAGGTTCTACTCTGAAGGTTCTACCGGCACCC CAAGAGGGTCAGGCTCAGAGGATTCGTTTGTTAAAAGGGAAAGGGCCACGGAAGACTTCTTCGTTAGGCAGCGTGAGAAGGAGCAACTACGCCATTTGAAAGAACAACTGGAAAAACAACGAAAGAAGATTGATTCTTTGGAAAATAAAATTGACTCGATGACCAAATAA.
[0061] SEQ ID NO. 2: MLPRSALARSLQLQRGVAARFYSEGSTGTPRGSGSEDS FVKRERATEDFFVRQREKEQLRHLKEQLEKQRKKIDSLENKIDSMTK.
[0062] Example 2: Construction and identification of recombinant bacteria
[0063] The recombinant plasmid pGAPZαA / Inh1 identified by sequencing was linearized with endonuclease Avr II and electroporated into a long-chain dicarboxylic acid-producing Candida albicans strain (CGMCC NO.0356). Then, clones were screened on a YPD agar plate containing Zeocin antibiotic (100 μg / ml) to obtain recombinant engineered bacteria containing pGAPZαA / Inh1.
[0064] Example 3: Comparative fermentation experiment of recombinant bacteria and control bacteria
[0065] The recombinant bacteria pGAPZαA / Inh1 and the single colony containing the empty plasmid pGAPZαA were selected and activated on the seed culture medium for 24 hours. The above activated cultured seed solution was inoculated into the fermentation medium at an inoculum of 20% (V / V), and the fermentation culture was carried out at 30°C and 300rpm. After 48 hours, 2% (V / V) of fresh fermentation medium was added every day according to the fermentation volume, and 2% (V / V) of normal dodecane, tridecane or hexadecane was added every day at the same time, and the addition was continued for 4 days, and the total culture was 144 hours (6 days).
[0066] The fermentation results are shown in Table 1. The glucose consumption rate and the production of dodeca-carbon long-chain dibasic acid of the recombinant bacteria increased by 69.7% and 59.4% respectively compared with the control bacteria.
[0067] The fermentation results are shown in Table 2. The glucose consumption rate and the production of 13-carbon long-chain dibasic acid of the recombinant bacteria increased by 78.4% and 65.5% respectively compared with the control bacteria.
[0068] The fermentation results are shown in Table 3. The glucose consumption rate and the production of 16-carbon long-chain dibasic acid of the recombinant bacteria increased by 77.2% and 90.3% respectively compared with the control bacteria.
[0069] In addition, the growth rate and dry weight of the recombinant bacteria were significantly improved compared with the control bacteria.
[0070] Table 1. Comparison of dodeca-long carbon chain dicarboxylic acid fermentation between control bacteria 0356-pGAPZαA and engineered bacteria 0356-pGAPZαA / Inh1
[0071]
[0072] Table 2. Comparison of 13-carbon long-chain dicarboxylic acid fermentation between control bacteria 0356-pGAPZαA and engineered bacteria 0356-pGAPZαA / Inh1
[0073]
[0074] Table 3. Comparison of 16-carbon long-chain dibasic acid fermentation between control bacteria 0356-pGAPZαA and engineered bacteria 0356-pGAPZαA / Inh1
[0075]
[0076]
[0077] It should be noted that when the claims of the present invention involve numerical ranges, it should be understood that the two endpoints of each numerical range and any numerical value between the two endpoints can be selected. In order to avoid redundancy, the present invention describes a preferred embodiment.
[0078] Although the preferred embodiments of the present invention have been described, those skilled in the art may make other changes and modifications to these embodiments once they have learned the basic creative concept. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention.
[0079] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
Claims
1. Application of a recombinant plasmid in improving the production intensity of long-chain dicarboxylic acid producing strains, It is characterized in that The recombinant plasmid carries the Inh1 gene shown in SEQ ID NO.1, and the expression vector is pGAPZαA; The long-chain dibasic acid-producing strain is Candida tropicalis with a deposit number of CGMCC NO.0356 ( Candida tropicalis ) mutant strain PF-UV-56; The long carbon chain dibasic acid is a dodecacarbon long carbon chain dibasic acid, a thirteencacarbon long carbon chain dibasic acid and a hexadecane long carbon chain dibasic acid.
2. The use according to claim 1, It is characterized in that The construction method of the recombinant plasmid comprises the following steps: The Inh1 gene was inserted between the EcoR I and Xba I sites of the pGAPZαA expression vector to obtain the recombinant plasmid.
3. The use according to claim 2, It is characterized in that The application comprises the following steps: The recombinant plasmid was linearized with endonuclease Avr II, and then transferred into the tropical Candida mutant strain PF-UV-56, and the recombinant bacteria were obtained by screening positive clones; The recombinant bacteria are used, dodecane, tridecane and / or hexadecane are used as substrates, fermented and cultured, and fermentation products are collected to obtain dodecane long-chain dibasic acid, tridecane long-chain dibasic acid and / or hexadecane long-chain dibasic acid.
4. The use according to claim 3, It is characterized in that Fermentation cultures include: The recombinant bacteria are activated and inoculated into a fermentation medium, cultured at 26-34° C. for 1-2 days, and then fresh fermentation medium and dodecane, tridecane and / or hexadecane are added every day for 3-4 consecutive days.
Citation Information
Cited By
Method for improving production intensity of long-carbon-chain dicarboxylic acid
CN119351483A
A method for increasing the production intensity of long-chain dibasic acids
CN119351483B
